• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Mobile Telehealth Company Medici Acquires DocbookMD

Share:

November 12, 2018

Medici today announced its acquisition of secure healthcare messaging company DocbookMD at the Exponential Medicine conference in San Diego, California. The acquisition will offer doctors and other healthcare providers access to a broad range of mobile communication and telehealth tools that will fundamentally change how doctors practice medicine. In the arrangement, Medici will assume DocbookMD’s technical assets, people and customer contracts including those with state medical associations.

Austin-based DocbookMD was founded in 2008 as an early collaboration tool and offers a secure text messaging application that allows medical professionals to communicate with one another. The DocbookMD application is endorsed by more than 42 state medical associations and 400 county medical associations. The mobile application supports more than 25,000 active doctors. Medici acquires DocbookMD from Scrypts, Inc. and financial terms of the acquisition were not disclosed.

Medici, also headquartered in Austin, provides a global HIPAA-compliant mobile app with secure text, voice and video messaging and allows doctors to provide virtual healthcare to patients. In addition to offering colleague-communication capabilities, the platform offers more than a dozen innovative features including in-app billing, e-prescribe prescriptions and e-refer referrals. Medici empowers doctors, veterinarians, psychologists and other healthcare providers to provide patient care from anywhere.

Medici plans to provide continued technology support for DocbookMD. Existing users and partners should expect uninterrupted usage of data, functionality and connectivity. Medici CEO & Founder, Clinton Phillips stated, “We are delighted to be acquiring one of the most trusted resources for doctors. Medici and DocbookMD are so well-aligned with each other, and with the interests of medical associations in helping doctors live and practice at the highest level.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Original DocbookMD co-founder, Tracey Haas, DO, MPH, is supportive of the move, stating: “We are thrilled to see DocbookMD find a home at Medici, with its physician-centric technology that continues to push mobile health beyond secure messaging. We are excited to see how Medici and DocbookMD can help healthcare professionals better meet patient needs in this new era of medicine.”

The Medici acquisition of DocbookMD is the company’s first major acquisition following a recent $22 million private capitalization round

Medici also announced the addition of Anne Jude Hunt, Ph.D., as vice president and head of product. Dr. Hunt comes to Medici from San Francisco with strong Artificial Intelligence and semantic sciences expertise.

Date: November 12, 2018

Source: MedIndia

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Beyond AI: Healthcare entering an exciting, new phaseBeyond AI: Healthcare entering an exciting, new phase
  • Ibex Launches AI-powered Diagnostic System for Detecting Breast Cancer in PathologyIbex Launches AI-powered Diagnostic System for Detecting Breast Cancer in Pathology
  • Verantos Awarded Nih Grant to Fund Clinical Phenotyping in Real-World EvidenceVerantos Awarded Nih Grant to Fund Clinical Phenotyping in Real-World Evidence
  • Arlington Capital Partners Acquires a Majority Interest in Riverpoint MedicalArlington Capital Partners Acquires a Majority Interest in Riverpoint Medical
  • Predicting Drug Safety Through Systems ToxicologyPredicting Drug Safety Through Systems Toxicology
  • In Second Acquisition This Month, Amgen Buys Rodeo for $721 MillionIn Second Acquisition This Month, Amgen Buys Rodeo for $721 Million
  • Vericred Nabs $23M for API Platform Exchange for Health Insurance & Employee BenefitsVericred Nabs $23M for API Platform Exchange for Health Insurance & Employee Benefits
  • Wellframe Raises $20m in Series C FundingWellframe Raises $20m in Series C Funding

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications